Evidence map›Paper›PMID 42852118›Full record

ArticleFrontiers in neuroscience2026

Comparison of automated white matter lesion segmentation approaches for use in large, multi-site data analyses in Parkinson's disease.

Sarah Al-Bachari, So Hoon Yoon, Phoebe Emson, Shauna Angell, John Cain, Aswin Abraham, Azeem Chughtai, Edward Sizer, Edwin Barnes, Maryam Al-Wardy and 16 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sarah Al-BachariDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, England, United Kingdom.
So Hoon YoonDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
Phoebe EmsonLancaster Medical School, Lancaster University, Lancaster, England, United Kingdom.
Shauna AngellDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, England, United Kingdom.
John CainDepartment of Radiology, Royal Preston Hospital, Lancashire Teaching Hospitals, Preston, Lancashire, England, United Kingdom.
Aswin AbrahamFaculty of Medical Sciences, University College London, London, England, United Kingdom.
Azeem ChughtaiLancaster Medical School, Lancaster University, Lancaster, England, United Kingdom.
Edward SizerSchool of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
Edwin BarnesSchool of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
Maryam Al-WardyDepartment of Behavioral Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Siddarth KannanDepartment of Neurosurgery, The Walton Centre, Liverpool, England, United Kingdom.
Rohan Paul-ThaperSchool of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England, United Kingdom.
Joanna BrightSocial, Genetic and Developmental Psychiatry Centre, King's College London, London, England, United Kingdom.
Conor Owens-WaltonImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States.
Corey T McMillanDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Johannes C KleinDivision of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford, Oxford, England, United Kingdom.
Ludovica GriffantiDepartment of Psychiatry, Oxford Centre for Human Brain Activity, Centre for Integrative Neuroimaging (OxCIN), University of Oxford, Oxford, England, United Kingdom.
Sophia I ThomopoulosImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States.
Neda JahanshadImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States.
Paul M ThompsonImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States.
Ysbrand D van der WerfDepartment of Anatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Chris VriendDepartment of Anatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Laura M ParkesFaculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, England, United Kingdom.
Hedley C A EmsleyLancaster Medical School, Lancaster University, Lancaster, England, United Kingdom.
Anette SchragDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, England, United Kingdom.
Hamied A HaroonFaculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, England, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The vascular role in Parkinson's disease (PD) is emerging, yet the literature remains conflicted, motivating large-data analyses with greater statistical power. White matter lesions (WML) are an accepted imaging marker of small vessel disease. Accurate automated WML segmentation techniques are crucial for large-scale studies; however, evaluation of the optimum approach in PD is lacking. This study evaluated automated WML segmentation algorithms to determine the most accurate and reliable method, among those selected, for multi-site large data analysis in PD. Methods: We assessed whole-brain volumetric T1-weighted and FLAIR images from 201 PD patients (mean age, 66.6 ± 7.86 years) and 64 healthy controls (HC; mean age, 66.3 ± 8.67) across three datasets composed of different scanners, imaging parameters and lesion loads. WML were manually segmented to provide the gold standard, and four freely available automated algorithms were evaluated, FSL's BIANCA, FreeSurfer, SPM's LST-LPA and U-Net-pgs, using the performance metrics: Dice score, Hausdorff distance, recall, precision, F1 score, log absolute volume difference (LOGAVD) and intraclass correlation coefficient (ICC). Sub-analyses were performed based on lesion load, lobar regions and acquisition parameters. Results: U-Net-pgs produced the highest Dice score (PD: 0.46 ± 0.21; HC: 0.39 ± 0.21), recall (PD: 0.75 ± 0.24; HC: 0.58 ± 0.26), precision (PD: 0.48 ± 0.24; HC: 0.62 ± 0.25), F1 score (PD: 0.53 ± 0.21; HC: 0.54 ± 0.20) and ICC (PD: 0.87; HC: 0.89) and lowest Hausdorff distance (PD: 8.89 ± 3.96; HC: 6.33 ± 2.91) and LOGAVD (PD: 0.31 ± 0.31; HC 0.27 ± 0.30) across PD and HC. U-Net-pgs also showed overall superior performance in all lesion loads for PD and across brain regions in both PD and HC. Conclusion: Overall, of those we evaluated, U-Net-pgs emerged as the highest performing automated method across lesion loads and brain regions, for WML segmentation in PD and HC. The accuracy and reliability of U-Net-pgs, across various scanner and image acquisition parameters, make it a promising tool for large-scale analyses, facilitating future research investigating WML in PD.

Indexed as

automated segmentationmagnetic resonance imagingmulti-site dataParkinson’s diseasewhite matter hyperintensitieswhite matter lesions

Identifiers

PMID42852118
PMCPMC13647306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.